Earnings History Data for Medicenna Therapeutics (MDNAF) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Medicenna Therapeutics
Medicenna Therapeutics Corp is a clinical stage immuno-oncology company. It is engaged in developing engineered versions of IL-2, IL4 and IL13 cytokines called Superkines and Empowered Cytokines ECs for the treatment of cancer. Medicenna Therapeutics Corp is based in Toronto, Canada.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-02-2024 | PM | MDNAF | Medicenna Therapeutics | 34.00 | -0.05 | -0.05 | 0.00 | Medicenna Therapeutics GAAP EPS of -C$0.07 [2/14/2024 7:56 AM] |
0.63 | 0.13 (27.17%) |
0.0 | 0.0 (0.00%) |
0.15 - 0.84 | 553,263 | 450,000 | 0 | ||
| 14-11-2023 | PM | MDNAF | Medicenna Therapeutics | 31.00 | -0.05 | -0.05 | 0.00 | 0.3710 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.15 - 0.84 | 63,072 | 450,000 | 0 | |||
|
|
||||||||||||||||||